Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21391758 | 0.79 | — | — | |
| SCHEMBL21391830 | 0.74 | — | — | |
| SCHEMBL13290621 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL17821472 | 0.70 | — | — | |
| SCHEMBL13735000 | 0.70 | — | — | |
| SCHEMBL21391800 | 0.70 | — | — | |
| SCHEMBL22864327 | 0.62 | NOS3 (0.32) | — | |
| SCHEMBL21322305 | 0.61 | PDCD1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL9326277 | 0.60 | PDCD1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL30914668 | 0.58 | PDCD1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210017162-A1 | NEURITE OUTGROWTH PROMOTERS AND USES THEREOF | UNIVERSITY OF MIAMI | 2021-01-21 | — | — | US | disclosed |
| WO-2019183369-A1 | NEURITE OUTGROWTH PROMOTERS AND USES THEREOF | UNIVERSITY OF MIAMI (US) | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017162-A1 | NEURITE OUTGROWTH PROMOTERS AND USES THEREOF | BDNF, NGF, GAP43 | NPC1 839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.